Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
20.85
+0.14 (0.68%)
At close: Jun 24, 2026, 4:00 PM EDT
20.82
-0.03 (-0.14%)
After-hours: Jun 24, 2026, 7:54 PM EDT
Monte Rosa Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Reiterates $30 → $31 | Buy | Reiterates | $30 → $31 | +48.68% | May 11, 2026 |
| Wedbush | Wedbush | Buy Maintains $37 | Buy | Maintains | $37 | +77.46% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +77.46% | May 8, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $34 → $30 | Buy | Maintains | $34 → $30 | +43.88% | Mar 18, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $30 → $29 | Buy | Reiterates | $30 → $29 | +39.09% | Mar 18, 2026 |
| Jefferies | Jefferies | Buy Maintains $22 → $31 | Buy | Maintains | $22 → $31 | +48.68% | Jan 7, 2026 |